Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin-clavulanate vs Amoxicillin vs Placebo in Acute Otitis Media in Children
NCT07878910Phase 4Not yet recruiting
- Sponsor
- Kuopio University Hospital
- Start
- Nov 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of amoxicillin and clavulanic acid in acute otitis media (AOM) (3 arms), sponsored by Kuopio University Hospital. Primary endpoint: Symptoms of the child measured with AOM SOS symptom score 6.0 at 14 days. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
amoxicillinclavulanic acid
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT07878910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07878910.